Curis
CRIS
#11142
Rank
S$3.09 M
Marketcap
S$1.28
Share price
-8.26%
Change (1 day)
-41.57%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -S$8.62 Million

According to Curis's latest financial reports the company's current earnings are S$7.06 Million. In 2025 the company made an earning of -S$6.89 Million, an increase over its 2024 earnings that were of -S$54.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$8.62 Million25.17%
2025 -S$6.89 Million-87.38%
2024 -S$54.57 Million-5.77%
2023 -S$57.91 Million-13.1%
2022 -S$66.64 Million27.52%
2021 -S$52.26 Million65.09%
2020 -S$31.66 Million-9.1%
2019 -S$34.83 Million-4.73%
2018 -S$36.55 Million-41.95%
2017 -S$62.96 Million-14.37%
2016 -S$73.53 Million3.55%
2015 -S$71 Million271.52%
2014 -S$19.12 Million76.64%
2013 -S$10.82 Million
2011 -S$9.19 Million27.76%
2010 -S$7.2 Million-43.87%
2009 -S$12.82 Million-23.44%
2008 -S$16.74 Million56.66%
2007 -S$10.69 Million-16.71%
2006 -S$12.83 Million-36.92%
2005 -S$20.34 Million156.25%
2004 -S$7.94 Million-37.24%
2003 -S$12.65 Million-93.34%
2002 -S$0.19 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.51 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.24 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$78.95 Million 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.27 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.4 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$28.32 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$75.39 M-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA